What you need to address for successful artificial intelligence adoption and enterprise imaging integration.
With so many artificial intelligence (AI) products flooding the imaging industry, the radiology space has taken on a gold rush feel. Vendors are in a frenzied battle to position themselves as the leader with the best tools available – but, there’s still a lack of over-arching standardization on how to implement and integrate these products.
In a session during the Society for Imaging Informatics in Medicine (SIIM) 2021 Virtual Annual Meeting, Florent Saint-Clair, executive vice president at Dicom Systems, outlined four major challenges facilities must address before they can successfully adopt AI algorithms and integrate enterprise imaging solutions.
“We can’t put our heads in the sand as the use of AI is going to bet more and more intensive,” he said. “This ecosystem is going to make sure the gold rush becomes a very well-structured industry.”
For more SIIM 2021 coverage, click here.
To reach that goal, he suggested you consider these obstacles.
Challenge No. 1: Insufficient Use of Industry Standards
In many instances, AI developers have developed their algorithms using basic JPG images. Products developed like this cannot take full advantage of the metadata that images contain. When you’re talking with AI developers, make sure their algorithm has been trained with and makes full use of DICOM data, he said, and clarify if they use DICOM, HL7, or DICOM Web, etc. In addition, make sure your workflow isn’t going to create an expectation that prior images will be pulled in with the primary image.
Challenge No. 2: To Cloud or Not to Cloud
Technology can be made available to you in a variety of ways – does this vendor offer it strictly in the cloud, such as Google, Amazon, or Azure, or can it also be deployed on premises? If data cannot fit in Docker in your own server, you will need to address the need for encrypted communication that can move the images safely, as well as data de-identification.
Challenge No. 3: Limited Workflow Knowledge
DICOM, HL7, and PACS workflow have been around for quite a while, but using them involves jargon that is unfamiliar to many AI developers. Before selecting a tool, check to see the algorithm has been developed with workflow in mind – not just the core technology that is part of the machine learning itself, he said.
You should also be aware that not everyone is 100-percent comfortable with using DICOM Web yet. Find out where your vendor stands and whether you will need to plan for additional hurdles when trying to communicate with them.
Challenge No. 4: Inconsistent Results Delivery
This is, perhaps, the biggest, most important challenge surrounding AI adoption and enterprise imaging integration, he said. You must be sure your data can be delivered to the right place in the right format. For example, results that should come in as a DICOM overlay can come through as a blob on top of the image if the vendor is not conforming to the right industry standards. You can also run into HL7 problems if the proper HL7 connection isn’t in place. If the system is set up correctly, he said, results can be shared seamlessly.
“Every piece of the workflow has different things that the AI vendor needs to think about before they develop their AI,” Saint-Clair said. “They need to know what to do at what point in the workflow to add value without having to re-invent workflow.”
Ultimately, he said, addressing these four challenges will help you identify your needs and what you should pursue from a vendor.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the